CISPLATIN KOCAK 10mg / 20ml perfusive solution concentrate medication leaflet

L01XA01 cisplatin • Antineoplastic and immunomodulating agents | Other antineoplastic agents | Platinum compounds

Cisplatin is a chemotherapy medication used for the treatment of various types of cancer, including testicular, ovarian, bladder, and lung cancer. It works by binding to the DNA of tumor cells, inhibiting their replication and inducing cell death.

The medication is administered intravenously, as directed by a doctor, usually in a hospital or specialized clinic. It is important for patients to be monitored to prevent severe side effects.

Patients should be aware of potential side effects, such as nausea, vomiting, kidney dysfunction, or ototoxicity. It is important to inform the doctor of any unusual symptoms.

Common side effects include nausea, vomiting, and fatigue. In rare cases, severe reactions such as kidney failure or hearing loss may occur. Patients should be informed of these risks before starting treatment.

General data about CISPLATIN KOCAK 10mg / 20ml

Substance: cisplatin

Date of last drug list: 01-06-2022

Commercial code: W66247001

Concentration: 10mg / 20ml

Pharmaceutical form: perfusive solution concentrate

Quantity: 1

Product type: generic

Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

Manufacturer: KOCAK FARMA ILAC VE KIMYA SANAYI A.S. - TURCIA

Holder: CN UNIFARM S.A. - ROMANIA

Number: 453/2019/01

Shelf life: 24 months

Pharmaceutical forms available for cisplatin

Concentrations available for cisplatin

0.5mg/ml, 10mg, 10mg/20ml, 1mg/1ml, 1mg/ml, 25mg/50ml, 50mg, 50mg/100ml

Other substances similar to cisplatin